Achmea Investment Management B.V. Boosts Holdings in The Clorox Company (NYSE:CLX)

Achmea Investment Management B.V. raised its holdings in The Clorox Company (NYSE:CLX - Free Report) by 263.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 16,810 shares of the company's stock after purchasing an additional 12,186 shares during the quarter. Achmea Investment Management B.V.'s holdings in Clorox were worth $2,475,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in CLX. Redwood Park Advisors LLC purchased a new stake in shares of Clorox during the 4th quarter worth about $26,000. Millstone Evans Group LLC purchased a new stake in shares of Clorox during the 4th quarter worth about $31,000. Wood Tarver Financial Group LLC purchased a new stake in shares of Clorox during the 4th quarter worth about $31,000. GKV Capital Management Co. Inc. purchased a new stake in shares of Clorox during the 4th quarter worth about $32,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in shares of Clorox during the 4th quarter worth about $33,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CLX has been the topic of several recent analyst reports. Jefferies Financial Group lowered their target price on shares of Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research note on Thursday. Barclays decreased their price target on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating on the stock in a research note on Wednesday, May 7th. Citigroup decreased their price target on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a research note on Monday, April 14th. UBS Group decreased their price target on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating on the stock in a research note on Thursday, April 17th. Finally, Wells Fargo & Company decreased their price target on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $149.50.

Clorox Stock Up 0.9%

CLX stock opened at $119.09 on Friday. The company has a market cap of $14.68 billion, a price-to-earnings ratio of 21.38, a PEG ratio of 2.70 and a beta of 0.54. The company has a current ratio of 0.74, a quick ratio of 0.44 and a debt-to-equity ratio of 13.07. The Clorox Company has a 12 month low of $117.35 and a 12 month high of $171.37. The firm has a 50-day moving average of $131.21 and a two-hundred day moving average of $145.14.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a net margin of 9.89% and a return on equity of 324.23%. The firm's revenue was down 8.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.71 EPS. As a group, analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber purchased 4,000 shares of the business's stock in a transaction dated Wednesday, May 7th. The stock was acquired at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the acquisition, the director now directly owns 4,000 shares of the company's stock, valued at approximately $546,280. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.57% of the company's stock.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.